Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Panitumumab, Cisplatin, and Radiation in Head and Neck Cancer
NCT00798655Phase 2Completed
- Start
- Nov 2007
- Primary completion
- Jun 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in squamous cell carcinoma of the head and neck (HNSCC). Started Nov 2007; status: completed.
02
Drugs
panitumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00798655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798655.